Influenza Vaccine(Split Virion), Inactivated, Trivalent (ZFA02 Adjuvant,Anhui Zhifei Longcom Biologic Pharmacy)

三价流感病毒裂解疫苗（ZFA02佐剂，智飞龙科马生物制药）

Report date: 2025/04/01 10:14:06

Base Information

Drug NameInfluenza Vaccine(Split Virion), Inactivated, Trivalent (ZFA02 Adjuvant,Anhui Zhifei Longcom Biologic Pharmacy)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A